The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...

We also have our exploratory programs evaluating lore that in hypertension and chronic kidney disease, as well as hypertension and obstructive sleep apnea ... In addition, during the event, the KOLs ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported its financial results for the fourth quarter and full year ending ...

This past year was important for the development of lorundrostat, and the entire Mineralys team contributed to the execution of our clinical ...

Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – – Completed enrollment in Explore-CKD Phase 2 trial and anticipate ...

An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that primary aldosteronism, when left untreated, is extremely dangerous. Strong ...

Baxdrostat is a drug that reduces aldosterone levels in the body to treat high blood pressure and other conditions. It's an aldosterone synthase inhibitor (ASI) that's being studied as a treatment for ...

So, there will be exports of the CKD Proton eMas 7, but it won’t be to Indonesia. At the launch of the Geely EX5 in the republic last month, Geely said that the Proton eMas 7 twin will be ...

When it comes to making chili, knowing the difference between beans is important. It seems obvious that chili beans would be used for making a pot of delicious chili, so where do kidney beans fall ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the completion of enrollment for its Explore-CKD Phase 2 trial. The study is evaluating the efficacy and safety of lorundrostat, ...